Bookmark this page — the only place tracking real acceptance speed, FWCI and field-normalized citation data for this journal.

Journal decision profile

Lancet Rheumatology

Medicine

Elsevier BVUnited KingdompISSN 2665-9913eISSN 2665-9913

Visit homepage

6.72026 metrics scoreOpenAlex · CC0

50dmedian speedlatest 95 articles

$6,300publishing cost*verify with journal

Journal Metrics Score

Journal Metrics ScoreThe visible value is the 2026Journal Metrics Score: citations in the most recent complete year to the journal's works from the two prior years, divided by the number of those works — from OpenAlex open data (CC0).

2026

6.7

Journal Metrics Score 2026 · 2021–2024 window citedness 6.77.

Speed

SpeedMedian calendar days from manuscript received to accepted. It includes revision time and is not the journal's time to first decision.

PUBMED

50 days

Submission → acceptance · median · 95/100 recent articles.

APC / cost*

APC / cost*Costs are indicative and may exclude taxes, waivers, society discounts, or article-type charges. Always verify the journal's official website.

VERIFY

$6,300

Indicative journal-level APC. Verify current charges, taxes, waivers, discounts, and article-type fees with the journal.

At a glance

Journal decision profile

A visual summary for comparison—not a single black-box star rating.

Relative profile

Cost is intentionally excluded. Missing APC data is never converted to a zero-dollar fee or a fabricated cost score.

Raw values behind the shape

Always visible

Metrics Score

Metrics ScoreThe 2026 Journal Metrics Score, normalized within a comparable journal cohort for this preview.

6.72026 · OPENALEX

Source output rank

Source output rankLifetime journal-wide output rank among OpenAlex sources associated with the journal’s leading topic.

#159 / 1,132LIFETIME OUTPUT

Highly cited papers

Highly cited papersRecent works in the global top 10% after normalization by work type, year, and subfield.

30.2%FIELD-NORMALIZED TOP 10%

Field-normalized impact

Field-normalized impactMedian FWCI, where 1.0 is the expected citation level for comparable work.

0.67MEDIAN FWCI

Review speed

Review speedMedian submission-to-acceptance time from qualified PubMed records.

50 daysMEDIAN

Recent output

Recent outputAverage annual publication volume across the complete analysis window.

200 / yr2021–2024 AVG

Cost efficiency

Cost efficiencyNo score is assigned without a reliable journal-level cost.

—NOT SCORED

Field-normalized top 10% share30.2%

241 of 799 works · same type, year & subfield

Field-normalized top 1% share5.1%

41 works · same type, year & subfield

Median FWCI0.67×

Below field-year expectation

Source output rank#159

of 1,132 topic-associated OpenAlex sources by lifetime output

What does Median FWCI mean?

FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 0.67, so its typical recent paper runs about 33% below its field benchmark.

What does Top 10% Share mean?

30.2% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.

Submission to acceptance time (publication speed)

Among 95 recent articles with complete PubMed dates, the median time from received to accepted was 50 days. It includes revisions and is not the journal's time to first decision.

Publishing pattern

Publication volume and article mix

Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.

Works published by year

OpenAlex source records · 2019–2025

772019

2432020

2282021

1982022

1632023

2102024

1872025

Recent work-type mix

799 OpenAlex works · 2021–2024

Article93%

Erratum3.3%

Letter2.8%

Review0.6%

Paratext0.4%

OpenAlex article is broader than “original research.” PubMed Publication Types can add case-report and clinical-study detail.

Fit signals

Topics and medical subject coverage

OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.

Major MeSH signals

PubMed-indexed works

Lupus Erythematosus, SystemicArthritis, RheumatoidGiant Cell ArteritisScleroderma, SystemicRheumatic DiseasesCOVID-19RheumatologyAntirheumatic AgentsArthritis, Psoriatic

Leading OpenAlex topics

2021–2024 works

SARS-CoV-2 and COVID-19 Research66

Systemic Sclerosis and Related Diseases65

Rheumatoid Arthritis Research and Therapies63

Systemic Lupus Erythematosus Research57

Vasculitis and related conditions55

Autoimmune and Inflammatory Disorders Research46

COVID-19 Clinical Research Studies32

Spondyloarthritis Studies and Treatments28

Gout, Hyperuricemia, Uric Acid22

Salivary Gland Disorders and Functions21

Methodology: OpenAlex snapshot 2026-08-09. FWCI, percentile badges, topics, and type mix use 799 works published 2021–2024. Radar normalization is versioned in the cached profile, and no cost score is assigned without reliable APC data.